08:30 - 09:00

Welcome Coffee + Registration

09:00 - 09:15

09:15 - 09:30

Welcome from Luxembourg Representative
Josiane Entringer Conseiller - Ministère de l’Enseignement supérieur et de la Recherche

09:30 - 10:00

Keynote Speaker:

Prof. Wolfgang Oertel (University of Marburg)
  From Molecule to disease modifying clinical studies – the impact of the
  interaction of industry and academia  - exemplified by Parkinson’s disease

10:00 - 10:30

Coffee Break + Industry Booths

10:30 - 11:30

Precision Medicine Approaches from Fundamental Research

Stewart Campbell, Axial Biotherapeutics
  Targeting the Gut Microbiome in Parkinson’s Disease:
  A Promising Strategy for Intervention and Disease Modification

Mona Boyé, Ksilink
  How patient based disease models and artificial intelligence can revolutionize drug
  discovery in Parkinson’s Disease

Richard Wade-Martins, Professor of Molecular Neuroscience, University of Oxford
  Parkinson’s iPSC-derived neurons: from molecular mechanisms to target discovery

11:30 - 12:30

Innovative Technologies for Better Patient Care

Daniel Weiss – Research leader, Tübingen Deep Brain Stimulation
  Cutting edge technology for better treatment outcomes in advanced
  Parkinson’s disease?

Nicholas Maling, Deep Brain Stimulation Scientist, Boston Scientific
  A novel platform for visualization-based programming in DBS

Chantal Herberz, Portabiles-HCT
  Step by step - gait analysis for digital health concepts in Parkinson's disease

12:30 - 14:00

Standing Lunch + Industry Booths

14:00 - 15:00

Innovative Lab-based Technologies and Automation

Malte Weber, Beckman Coulter
  Current working title is: Challenges to move automation of research workflows
  to market ready solutions: Automated Cell Culture work stations

Maria Savino, LabCyte
  When liquid handling innovation has a sound effect on precise medicine

Jens Christian Schwamborn, Professor of Cellular and Developmental Biology,
University of Luxembourg
  Human brain organoids for patient specific in vitro modeling of Parkinson’s disease.

15:00 - 15:30

Trends in Innovative Research and Patient Care

Luc Brucher, Partner/Healthcare & Public Sector Leader, Deloitte

15:30 - 16:00

Conference Closure

16:00 - 16:30

Wrap-up Coffee